Here’s a scoop on the latest #nitrosamine updates!
As we kick off 2025, the FDA decided to make sure our champagne flutes weren't the only things hitting new limits on December 31st! 🍾 Here’s the scoop on the latest nitrosamine updates, because who needs fireworks when we have interim limits? 💔 Saying Goodbye to N-Nitroso-Duloxetine Duloxetine, your nitroso alter ego has been shown the door. You were fun while you lasted (not really), but there’s no room for toxic party crashers in our formulations. So long, and thanks for the headaches—literally. 🛑 Interim Limits Added for MNP Move over, caffeine—we now measure our patience in micrograms per day. The FDA is giving us new interim limits for Methylnitrosopiperazine (MNP), because what’s better than starting the year with a fresh batch of thresholds to obsess over in our risk assessments? 🤷♂️ N-Nitroso-Protriptyline Joins the Club Protriptyline’s nitrosamine cousin just RSVP’d to the impurities list, and let’s just say it’s not the kind of guest we wanted for our new year gathering. But hey, the more the merrier... in our spreadsheets, not our APIs! As pharmaceutical scientists, we might not party with nitrosamines, but we sure do work hard to keep them out of the drugs you trust. Here's to a cleaner, safer, nitrosamine-free 2025! 🥂✨